NorthWest Biotherapeutics Inc (NWBO)

[Gus McCrae]

That's pretty much it. The Flaskworks risk factor is also interesting and confirms that its impact is years away, assuming it works.

There was also this one:

It is possible that the standard of care for brain cancer could change before we complete our Phase III trial and analysis of its results, or before we are able to seek approval for commercialization.

The bolded is new...it's almost like this was written to taunt shareholders.